Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension

Hypertension Research

Volumn 31, Issue 12, 2008, Pages 2165-2175

  Sakairi, Akira ^a   Ishida, Junji ^a   Honjo, Kaori ^a   Inaba, Saki ^a   Nakamura, Shoko ^a   Sugiyama, Fumihiro ^a   Yagami, Ken Ichi ^a   Fukamizu, Akiyoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CREATINE KINASE; CREATINE KINASE MB; OLMESARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEART DISEASE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; IN VIVO STUDY; MATERNAL HYPERTENSION; MOUSE; NICK END LABELING; NONHUMAN; PATHOGENESIS; PREGNANCY ASSOCIATED HYPERTENSION; RECEPTOR BLOCKING; TRANSGENIC MOUSE; WEIGHT GAIN; WILD TYPE; ANIMAL; CARDIOMEGALY; DISEASE MODEL; DRUG EFFECT; FIBROSIS; HEART MUSCLE; HEART VENTRICLE REMODELING; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HYPERTENSION, PREGNANCY-INDUCED; IMIDAZOLES; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; TETRAZOLES; VENTRICULAR REMODELING;

EID: 61949330738     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.2165     Document Type: Article

References (54)

1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
2. LavoieOJL, Sigmund CD: Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology 2003; 144: 2179-2183.
3. Paul M, Mehr AP, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
4. Nasjletti A, Masson GMC: Studies on angiotensinogen formation in a liver perfusion system. Circ Res 1972; 30: 187-202.
5. Tewksbury DA: Angiotensinogen-biochemistry and molecular biology. in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, 1990, pp 1197-1216.
6. Chen Y, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992; 19: 456-463.
7. Rubattu S, Quimby FW, Sealey JE: Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens 1991; 9: 525-535.
8. Glorioso N, Atlas SA, Laragh JH, et al: Prorenin in high concentrations in human ovarian follicular fluid. Science 1986; 233: 1422-1424.
9. Howard RB, Pucell AG, Bumpus FM, et al: Rat ovarian renin: characterization and changes during the estrous cycle. Endocrinology 1988; 123: 2331-2340.
10. Brown MA, Wang J, Whitworth JA: The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens 1997; 19: 713-726.
11. Baker PN, Pipkin FB, Symonds EM: Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci (Lond) 1990; 79: 403-408.
12. Baker PN, Pipkin FB, Symonds EM: Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension. Clin Sci (Lond) 1992; 83: 89-95.
13. Gant NF, Daley GL, Chand S, et al: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682-2689.
14. Chesley LC, Talledo E, Bohler CS, et al: Vascular reactivity to angiotensin II and norepinephrine in pregnant and nonpregnant women. Am J Obstet Gynecol 1965; 91: 837-842.
15. Crowley SD, Tharaux PL, Audoly LP, et al: Exploring type I angiotensin (AT1) receptor functions through gene targeting. Acta Physiol Scand 2004; 181: 561-570.
16. 1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001; 7: 1003-1009.
17. Wallukat G, Homuth V, Fischer T, et al: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103: 945-952.
18. Zhou CC, Zhang Y, Irani RA, et al: Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008; 14: 855-862.
19. Takimoto E, Ishida J, Sugiyama F, et al: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996; 274: 995-998.
20. Saito T, Ishida J, Takimoto-Ohnishi E, et al: An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J 2004; 18: 388-390.
21. Takimoto-Ohnishi E, Saito T, Ishida J, et al: Differential roles of renin and angiotensinogen in the feto-maternal interface to the development of complications of pregnancy. Mol Endocrinol 2005; 19: 1361-1372.
22. Furuya M, Ishida J, Inaba S, et al: Impaired placental neovascularization in mice with pregnancy-associated hypertension. Lab Invest 2008; 88: 416-429.
23. Ishida J, Hashimoto T, Hashimoto Y, et al: Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004; 279: 26274-26279.
24. Ishizaka N, Saito K, Mitani H, et al: Iron overload augments angiotensin II-induced cardiac fibrosis and promotes neointima formation. Circulation 2002; 106: 1840-1846.
25. Garpvic VD, Hayman SRA Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007; 11: 613-622.
26. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM: Peripartum cardiomyopathy: A comprehensive review. Int J Cardiol 2007; 118: 295-303.
27. Hunter S, Robson SC: Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68: 540-543.
28. Mesa A, Carlos J, Hernandez A, et al: Left ventricular diastolic function in normal human pregnancy. Circulation 1999; 9: 511-517.
29. Valensise H, Novelli GP, Vasapollo B, et al: Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension. Hypertension 2001; 37: 1209-1215.
30. Novelli GP, Valensise H, Vasapollo B, et al: Left ventricular concentric geometry as a risk factor in gestational hypertension. Hypertension 2003; 41: 469-475.
31. Valensise H, Vasapollo B, Novelli GP, et al: Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension. BJOG 2006; 113: 1044-1052.
32. Zheng J, Bird IM, Chen DB, et al: Angiotensin II regulation of ovine fetoplacental artery endothelial functions: Interactions with nitric oxide. J Physiol 2005; 565: 59-69.
33. Hanssens M, Keirse MJ, Spitz B, et al: Angiotensin II levels in hypertensive and normotensive pregnancies. Br J Obstet Gynecol 1991; 98: 155-161.
34. Kalenga MK, Thomas K, de Gasparo M, et al: Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension. Clin Endocrinol (Oxf) 1996; 44: 429-433.
35. Sadoshima J, Izumo, S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993; 73: 413-423.
36. Hein L, Stevens ME, Barsh GS, et al: Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A 1997; 94: 6391-6396.
37. Paradis P, Dali-Youcef N, Paradis FW, et al: Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A 2000; 97 931-936.
38. Kudoh S, Komuro I, Hiroi Y, et al: Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice. J Biol Chem 1998; 273: 24037-24043.
39. Berk BC, Fujiwara K, Lehoux S: ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568-575.
40. Burstein B,MNattel S: Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
41. Crabos M, Roth M, Hahn AW, et al: Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest 1994; 93 2372-2378.
42. Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I: Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 1999; 100: 2093-2099.
43. Lijnen PJ, Petrov VV, Fagard RH: Angiotensin II.induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors. J Renin Angiotensin Aldosterone Syst 2001; 2: 117-122.
44. Tokuda K, Kai H, Kuwahara F, et al: Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2004; 43: 499-503.
45. Kabour A, Henegar JR, Devineni VR, Janicki JS: Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovasc Res 1995; 29: 543-548.
46. Nakamura K, Fushimi K, Kouchi H, et al: Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998; 98: 794-799.
47. 2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J Biol Chem 2005; 280: 18434-18441.
48. Skultetyova D, Filipova S, Riecansky I, et al: The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction. Recent Patents Cardiovasc Drug Discov 2007; 2: 23-27.
49. Schulz R, Heusch G: Angiotensin II in the failing heart. Kidney Blood Press Res 2005; 28: 349-352 (Short Communication).
50. Ohkuchi A, Hirashima C, Matsubara S, et al: Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151-159.
51. Hirashima C, Ohkuchi A, Arai F, et al: Establishing reference values for both total soluble fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res 2005; 28: 727-732.
52. Maynard SE, Min JY, Merchan J, et al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
53. Lu F, Longo M, Tamayo E, et al: The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 2007; 196: 396.e1-396.e7.
54. Zhou CC, Ahmad S, Mi T, et al: Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cell signaling. Hypertension 2008; 51: 1010-1019.